Cargando…
Regulatory Mechanism of MicroRNA Expression in Cancer
Altered gene expression is the primary molecular mechanism responsible for the pathological processes of human diseases, including cancer. MicroRNAs (miRNAs) are virtually involved at the post-transcriptional level and bind to 3′ UTR of their target messenger RNA (mRNA) to suppress expression. Dysfu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084905/ https://www.ncbi.nlm.nih.gov/pubmed/32138313 http://dx.doi.org/10.3390/ijms21051723 |
_version_ | 1783508830588502016 |
---|---|
author | Ali Syeda, Zainab Langden, Siu Semar Saratu’ Munkhzul, Choijamts Lee, Mihye Song, Su Jung |
author_facet | Ali Syeda, Zainab Langden, Siu Semar Saratu’ Munkhzul, Choijamts Lee, Mihye Song, Su Jung |
author_sort | Ali Syeda, Zainab |
collection | PubMed |
description | Altered gene expression is the primary molecular mechanism responsible for the pathological processes of human diseases, including cancer. MicroRNAs (miRNAs) are virtually involved at the post-transcriptional level and bind to 3′ UTR of their target messenger RNA (mRNA) to suppress expression. Dysfunction of miRNAs disturbs expression of oncogenic or tumor-suppressive target genes, which is implicated in cancer pathogenesis. As such, a large number of miRNAs have been found to be downregulated or upregulated in human cancers and to function as oncomiRs or oncosuppressor miRs. Notably, the molecular mechanism underlying the dysregulation of miRNA expression in cancer has been recently uncovered. The genetic deletion or amplification and epigenetic methylation of miRNA genomic loci and the transcription factor-mediated regulation of primary miRNA often alter the landscape of miRNA expression in cancer. Dysregulation of the multiple processing steps in mature miRNA biogenesis can also cause alterations in miRNA expression in cancer. Detailed knowledge of the regulatory mechanism of miRNAs in cancer is essential for understanding its physiological role and the implications of cancer-associated dysfunction and dysregulation. In this review, we elucidate how miRNA expression is deregulated in cancer, paying particular attention to the cancer-associated transcriptional and post-transcriptional factors that execute miRNA programs. |
format | Online Article Text |
id | pubmed-7084905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70849052020-03-23 Regulatory Mechanism of MicroRNA Expression in Cancer Ali Syeda, Zainab Langden, Siu Semar Saratu’ Munkhzul, Choijamts Lee, Mihye Song, Su Jung Int J Mol Sci Review Altered gene expression is the primary molecular mechanism responsible for the pathological processes of human diseases, including cancer. MicroRNAs (miRNAs) are virtually involved at the post-transcriptional level and bind to 3′ UTR of their target messenger RNA (mRNA) to suppress expression. Dysfunction of miRNAs disturbs expression of oncogenic or tumor-suppressive target genes, which is implicated in cancer pathogenesis. As such, a large number of miRNAs have been found to be downregulated or upregulated in human cancers and to function as oncomiRs or oncosuppressor miRs. Notably, the molecular mechanism underlying the dysregulation of miRNA expression in cancer has been recently uncovered. The genetic deletion or amplification and epigenetic methylation of miRNA genomic loci and the transcription factor-mediated regulation of primary miRNA often alter the landscape of miRNA expression in cancer. Dysregulation of the multiple processing steps in mature miRNA biogenesis can also cause alterations in miRNA expression in cancer. Detailed knowledge of the regulatory mechanism of miRNAs in cancer is essential for understanding its physiological role and the implications of cancer-associated dysfunction and dysregulation. In this review, we elucidate how miRNA expression is deregulated in cancer, paying particular attention to the cancer-associated transcriptional and post-transcriptional factors that execute miRNA programs. MDPI 2020-03-03 /pmc/articles/PMC7084905/ /pubmed/32138313 http://dx.doi.org/10.3390/ijms21051723 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ali Syeda, Zainab Langden, Siu Semar Saratu’ Munkhzul, Choijamts Lee, Mihye Song, Su Jung Regulatory Mechanism of MicroRNA Expression in Cancer |
title | Regulatory Mechanism of MicroRNA Expression in Cancer |
title_full | Regulatory Mechanism of MicroRNA Expression in Cancer |
title_fullStr | Regulatory Mechanism of MicroRNA Expression in Cancer |
title_full_unstemmed | Regulatory Mechanism of MicroRNA Expression in Cancer |
title_short | Regulatory Mechanism of MicroRNA Expression in Cancer |
title_sort | regulatory mechanism of microrna expression in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084905/ https://www.ncbi.nlm.nih.gov/pubmed/32138313 http://dx.doi.org/10.3390/ijms21051723 |
work_keys_str_mv | AT alisyedazainab regulatorymechanismofmicrornaexpressionincancer AT langdensiusemarsaratu regulatorymechanismofmicrornaexpressionincancer AT munkhzulchoijamts regulatorymechanismofmicrornaexpressionincancer AT leemihye regulatorymechanismofmicrornaexpressionincancer AT songsujung regulatorymechanismofmicrornaexpressionincancer |